Extrait

The aim of the study is to test whether neutralizing TNF-alpha with infliximab affects insulin resistance and phenotypical manifestations of the metabolic syndrome as fasting plasma insulin, total body fat, plasma lipid profile or vascular endothelial function in obese male subjects.

Critère d'inclusion

• obesity,Insulin Resistance,Metabolic syndrome

Liens

• ictrp
• nct